Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction

Kardiologia Polska

Volumn 72, Issue 4, 2014, Pages 339-344

  Szymanski, Filip M ^a   Karpinski, Grzegorz ^a   Platek, Anna E ^a   Majstrak, F ^a   Hrynkiewicz Szymanska, Anna ^a   Kotkowski, Marcin ^a   Puchalski, Bartosz ^a   Filipiaki, Krzysztof J ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Acute myocardial infarction type 2; Aetiology; Prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ANEMIA; ANGIOCARDIOGRAPHY; ARTERY EMBOLISM; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY; CORONARY ARTERY SPASM; DIABETES MELLITUS; DISEASE SEVERITY; DISEASES; DYSLIPIDEMIA; DYSPNEA; ELECTROCARDIOGRAM; FAINTNESS; FAMILY HISTORY; FEMALE; HEART DISEASE; HEART PACING; HEART PALPITATION; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TYPE 2 ACUTE MYOCARDIAL INFARCTION; COMPLICATION; CORONARY ARTERY DISEASE; HEART ARRHYTHMIA; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84928216004     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2013.0284     Document Type: Article

References (16)

1. Thygesen K, Alpert JS, White HD et al. Third universal definition of myocardial infarction. Eur Heart J, 2012; 33: 2551-2567.
2. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J, 2007; 28: 2525-2538.
3. Steg PG, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J, 2012; 33: 2569-2619.
4. Melberg T, Burman R, Dickstein K. The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study. Int J Cardiol, 2010; 139: 228-233.
5. Gallagher S, Jones DA, Anand V, Mohiddin S. Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms. Heart, 2012; 98: 974-981.
6. Tanaka H, Abe S, Yamashita T et al. Serum levels of cardiac troponin I and troponin T in estimating myocardial infarct size soon after reperfusion. Coron Artery Dis, 1997; 8: 433-439.
7. Chia S, Senatore F, Raffel OC et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Am Coll Cardiol Cardiovasc Interv, 2008; 1: 415-423.
8. Jiang BH, Nguyen QT, Tardif JC et al. Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction. Cardiovasc Pathol, 2011; 20: e85-e89.
9. Szymanski FM, Grabowski M, Filipiak KJ et al. Prognostic implications of myocardial necrosis triad markers' concentration measured at admission in patients with suspected acute coronary syndrome. Am J Emerg Med, 2007; 25: 65-68.
10. Waxman DA, Hecht S, Schappert J, Husk G. A model for troponin I as a quantitative predictor of in-hospital mortality. J Am Coll Cardiol, 2006; 48: 1755-1762.
11. Ambrose JA, Loures-Vale A, Javed U et al. Angiographic correlates in type 1 and 2 MI by the universal definition. J Am Coll Cardiol Cardiovasc Imag, 2012; 5: 463-464.
12. Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature. Arch Cardiovasc Dis, 2011; 104: 178-188.
13. Cannon CP, Gibson CM, Lambrew CT et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA, 2000; 283: 2941-2947.
14. Shiomi H, Nakagawa Y, Morimoto T et al. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. BMJ, 2012; 344: e3257.
15. Perk J, De Backer G, Gohlke H et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2012; 33: 1635-1701.
16. Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation, 2011; 124: 1774-1782.